1. Home
  2. TRIB vs ICCM Comparison

TRIB vs ICCM Comparison

Compare TRIB & ICCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Trinity Biotech plc

TRIB

Trinity Biotech plc

N/A

Current Price

$6.79

Market Cap

8.4M

Sector

Health Care

ML Signal

N/A

Logo IceCure Medical Ltd.

ICCM

IceCure Medical Ltd.

HOLD

Current Price

$0.98

Market Cap

8.3M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
TRIB
ICCM
Founded
1992
2006
Country
Ireland
Israel
Employees
N/A
N/A
Industry
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.4M
8.3M
IPO Year
1996
2013

Fundamental Metrics

Financial Performance
Metric
TRIB
ICCM
Price
$6.79
$0.98
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
★ $22.67
AVG Volume (30 Days)
13.2K
★ 167.9K
Earning Date
06-16-2026
11-18-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$35.89
$27.11
Revenue Next Year
N/A
$104.97
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.28
$0.13
52 Week High
$14.17
$9.54

Technical Indicators

Market Signals
Indicator
TRIB
ICCM
Relative Strength Index (RSI) 44.95 22.39
Support Level $6.85 $0.96
Resistance Level $7.45 $2.50
Average True Range (ATR) 0.88 0.10
MACD 0.04 0.03
Stochastic Oscillator 30.19 41.39

Price Performance

Historical Comparison
TRIB
ICCM

About TRIB Trinity Biotech plc

Trinity Biotech PLC is in the business of developing, manufacturing, and marketing clinical diagnostic products for clinical laboratory and point-of-care sections of the diagnostic market. Its products are used to detect autoimmune, infectious, sexually transmitted diseases, diabetes, and disorders of the liver and intestine. The company also provides raw materials to the life sciences and research industries globally. It markets products under the brand names Recombigen, Unigold, MarBlot, Mardx, Immublot, and others. Geographically, it has three segments, namely the Americas, Asia/Africa, and Europe, from which it derives a majority of its revenue from the Americas segment.

About ICCM IceCure Medical Ltd.

Icecure Medical Ltd is a commercial-stage medical device company. The company is engaged in the research, development, and marketing of cryoablation systems and technologies based on liquid nitrogen, or LN2, for treating tumors. Its cryoablation technology is a minimally invasive alternative to surgical intervention for tumors, including those found in the breast, lungs, kidneys, bones, and other indications.

Share on Social Networks: